Merrimack Pharmaceuticals

Listing Websites about Merrimack Pharmaceuticals

Filter Type:

Merrimack Pharmaceuticals

(6 days ago) Merrimack Pharmaceuticals, Inc. (the “Company”) is a biopharmaceutical company based in Cambridge, Massachusetts that is entitled to receive contingent milestone payments related to its sale of ONIVYDE® to Ipsen S.A. (“Ipsen”) in April 2017. The Company does not have any ongoing research or development activities and is seeking

Url: Visit Now

Category:  Pharmaceutical Detail Drugs


Merrimack Pharmaceuticals - Wikipedia

(5 days ago) Merrimack Pharmaceuticals is a pharmaceutical company based in Cambridge, Massachusetts, United States. They specialize in developing drugs for the treatment of cancer.
Merrimack's first FDA-approved drug was approved in 2015; Onivyde, a liposome encapsulated version of irinotecan is used for treating pancreatic adenocarcinoma. It was approved for use in the European Union the following year.

Url: Visit Now

Category:  Pharmaceutical,  Cancer Detail Drugs


Contact - Merrimack Pharmaceuticals

(4 days ago) Merrimack Pharmaceuticals, Inc. One Broadway, 14th floor Cambridge, MA 02142 617-720-8606. FOR ALL INQUIRIES [email protected]merrimack.com. MAILING ADDRESS One …

Url: Visit Now

Category:  Pharmaceutical Detail Drugs


Merrimack Pharmaceuticals, Inc. (MACK) Stock Price, …

(6 days ago) Merrimack Pharmaceuticals, Inc. Analyst Report: Gilead Sciences, Inc.Gilead Sciences is a California-based biopharmaceutical company that researches, develops, and sells therapies for …

Url: Visit Now

Category:  Pharmaceutical Detail Drugs


Merrimack Pharmaceuticals Announces Completion of Strategic …

(Just Now) CAMBRIDGE, Mass., May 30, 2019 /PRNewswire/ -- Merrimack Pharmaceuticals, Inc. (Nasdaq: MACK) today announced the completion of its review of strategic alternatives, following which the Company's Board of Directors is implementing a series of measures designed to extend Merrimack's cash runway into 2027 and preserve its ability to …

Url: Visit Now

Category:  Pharmaceutical Detail Drugs


Merrimack Pharmaceuticals (MACK) - Forbes

(9 days ago) At Merrimack Pharmaceuticals (MACK), a filing with the SEC revealed that on Tuesday, Director [] By MarketNewsVideo Former Contributor. Sep 30, 2014. Insiders Buy the Holdings of XBI ETF.

Url: Visit Now

Category:  Pharmaceutical Detail Drugs


Merrimack Pharmaceuticals Issues Letter to Shareholders

(5 days ago) About Merrimack. Merrimack Pharmaceuticals, Inc. is a biopharmaceutical company based in Cambridge, Massachusetts that is entitled to receive up to $455.0 million in contingent milestone payments related to its sale of ONIVYDE® to Ipsen S.A. in April 2017 and up to $54.5 million in contingent milestone payments related to its sale of anti-HER3

Url: Visit Now

Category:  Pharmaceutical Detail Drugs


Merrimack Pharmaceuticals Stock Forecast, Price & News

(6 days ago) Merrimack Pharmaceuticals' stock was trading at $2.76 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization. Since then, MACK stock has increased by 128.6% and is now trading at $6.31. View which stocks have been most impacted by COVID-19.

Url: Visit Now

Category:  Pharmaceutical,  Health Detail Drugs


Merrimack Pharmaceuticals (NASDAQ:MACK) Now Covered by …

(8 days ago) 2 days ago · Merrimack Pharmaceuticals Company Profile Merrimack Pharmaceuticals, Inc operates as a biopharmaceutical company. The company was incorporated in 1993 and is headquartered in Cambridge, Massachusetts.

Url: Visit Now

Category:  Pharmaceutical Detail Drugs


Working at Merrimack Pharmaceuticals Glassdoor

(3 days ago) Industry: Biotech & Pharmaceuticals. Revenue: $50 to $100 million (USD) Competitors: Unknown. Merrimack is a biopharmaceutical company based in Cambridge, Massachusetts that is outthinking cancer to ensure that patients and their families live fulfilling lives. Its mission is to transform cancer care through the smart design and development of

Url: Visit Now

Category:  Pharmaceutical,  Cancer Detail Drugs


Merrimack Pharmaceuticals (MACK) Stock Price, News & Info The …

(9 days ago) Merrimack Pharmaceuticals Inc is a biopharmaceutical company discovering developing and preparing to commercialize innovative medicines paired with companion diagnostics for …

Url: Visit Now

Category:  Pharmaceutical Detail Drugs


MACK Stock Price Merrimack Pharmaceuticals Inc. Stock Quote …

(8 days ago) Merrimack Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company. engages in discovering, developing, and commercializing medicines consisting of novel therapeutics paired with

Url: Visit Now

Category:  Pharmaceutical Detail Drugs


Merrimack Pharmaceuticals Inc Company Profile Cambridge, MA

(3 days ago) Company Description: Merrimack Pharmaceuticals Inc is located in Cambridge, MA, United States and is part of the Pharmaceutical and Medicine Manufacturing Industry. Merrimack Pharmaceuticals Inc has 72 total employees across all of its locations. There are 2 companies in the Merrimack Pharmaceuticals Inc corporate family.

Url: Visit Now

Category:  Pharmaceutical Detail Drugs


MACK Merrimack Pharmaceuticals Inc. Profile MarketWatch

(4 days ago) Merrimack Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company. engages in discovering, developing, and commercializing medicines consisting of …

Url: Visit Now

Category:  Pharmaceutical Detail Drugs


Merrimack to Lay Off Remaining Execs and Staff, Sell Assets

(1 days ago) Merrimack Pharmaceuticals will lay off its entire staff, including its leadership team, as the Cambridge, Mass.-based company looks to be in the midst of shutting down.. On Thursday, the company announced the results of a months-long strategic review that include the job cuts, as well as a deal with startup 14ner Oncology, Inc. Merrimack will sell its anti-Her3 …

Url: Visit Now

Category:  Pharmaceutical Detail Drugs


Merrimack Pharmaceuticals, Inc. (MACK) Stock Message Board

(2 days ago) Gavin MacBeath, PhD, is a founder of Merrimack and Head of Translational Medicine. Dr. MacBeath leads translational research and drives our innovative diagnostic programs, helping to ensure we get the right drug to the right patient at the right time. He is also a founder of Chestnut Pharmaceuticals, serves on the Scientific Advisory Board of

Url: Visit Now

Category:  Pharmaceutical Detail Drugs


Merrimack LinkedIn

(8 days ago) Merrimack is a biopharmaceutical company based in Cambridge, Massachusetts that is outthinking cancer to ensure that patients and their families …

Url: Visit Now

Category:  Pharmaceutical,  Cancer Detail Drugs


Merrimack Pharmaceuticals (NASDAQ:MACK) Earns Sell Rating …

(Just Now) Merrimack Pharmaceuticals Company Profile Merrimack Pharmaceuticals, Inc operates as a biopharmaceutical company. The company was incorporated in 1993 and is headquartered in Cambridge, Massachusetts.

Url: Visit Now

Category:  Pharmaceutical Detail Drugs


Merrimack Pharmaceuticals Careers and Employment Indeed.com

(2 days ago) Merrimack pharma is a very fast paced, innovative, patient centric culture. The company culture is exceptional, where all areas of the company collaborate, and interact. With a new scientific platform, exciting, and innovative company. Senior Quality Control Analyst in Cambridge, MA. 3.0.

Url: Visit Now

Category:  Health Detail Drugs


Merrimack Partnering 2020 - Merrimack Pharmaceuticals

(4 days ago) Partnering Opportunities TNFR2 Agonist Antibody Program (MM-401) • Exciting Immuno-oncology Drug Candidate Against Novel Immunotherapy Target with Opportunity

Url: Visit Now

Category:  Health Detail Drugs


Merrimack Pharmaceuticals, Inc. (MACK) Latest Stock News

(2 days ago) Merrimack Pharmaceuticals, Inc. Analyst Report: Regeneron Pharmaceuticals, Inc. Regeneron Pharmaceuticals discovers, develops, and commercializes products that fight eye disease, cardiovascular

Url: Visit Now

Category:  Pharmaceutical Detail Drugs


Merrimack Pharmaceuticals, Inc. (MACK) Stock Price Today, Quote …

(6 days ago) Company Profile. Merrimack Pharmaceuticals, Inc. operates as a biopharmaceutical company. The company was incorporated in 1993 and is headquartered in Cambridge, Massachusetts. More

Url: Visit Now

Category:  Pharmaceutical Detail Drugs


Abstract: AACR-4846 MM-401, a novel anti-TNFR2 antibody …

(3 days ago) All data unpublished and on file at Merrimack Pharmaceuticals, Inc. Cross-reference Sampson et al. A novel human TNFR2-antibody (MM-401) modulates T cell responses Fulton et al. Mechanism of action of a novel agonist TNFR2-antibody that induces co- in anti-cancer immunity. AACR 2019, Abstract #555.

Url: Visit Now

Category:  Pharmaceutical,  Cancer Detail Drugs


Merrimack Pharmaceuticals, Inc. Common Stock (MACK)

(Just Now) Merrimack Pharmaceuticals, Inc. Common Stock (MACK) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets.

Url: Visit Now

Category:  Pharmaceutical Detail Drugs


Merrimack Pharmaceuticals - Crunchbase Company Profile

(5 days ago) Phone Number (617) 441-1000. Merrimack Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery, design, and development of therapies for the treatment of diseases in the areas of autoimmunity and cancer. It develops MM-093, a human alpha-fetoprotein for the treatment of patients with rheumatoid arthritis and psoriasis; and

Url: Visit Now

Category:  Pharmaceutical,  Cancer Detail Drugs


Merrimack Pharmaceuticals, Inc. (MACK) Stock Historical Prices

(4 days ago) Discover historical prices for MACK stock on Yahoo Finance. View daily, weekly or monthly format back to when Merrimack Pharmaceuticals, Inc. stock was issued.

Url: Visit Now

Category:  Pharmaceutical Detail Drugs


Merrimack Pharmaceuticals Reviews Glassdoor

(9 days ago) Merrimack Pharmaceuticals has an overall rating of 3.2 out of 5, based on over 48 reviews left anonymously by employees. 46% of employees would recommend working at Merrimack Pharmaceuticals to a friend and 25% have a positive outlook for the business. This rating has improved by 1% over the last 12 months. Does Merrimack Pharmaceuticals pay

Url: Visit Now

Category:  Pharmaceutical Detail Drugs


Merrimack Pharmaceuticals Company Profile: Stock Performance …

(7 days ago) Merrimack Pharmaceuticals Inc is a biotechnology company that discovers, develops, and commercializes innovative medicines that consist of novel therapeutics paired with diagnostics to treat cancer. The company's core approach to systems biology is to apply multidisciplinary capabilities to build functional and predictive computational models

Url: Visit Now

Category:  Pharmaceutical,  Cancer Detail Drugs


Head to Head Analysis: Merrimack Pharmaceuticals …

(2 days ago) Merrimack Pharmaceuticals, Inc. operates as a biopharmaceutical company. The company was incorporated in 1993 and is headquartered in Cambridge, Massachusetts. About Centessa Pharmaceuticals (Get

Url: Visit Now

Category:  Pharmaceutical Detail Drugs


Merrimack Pharmaceuticals Employee Reviews with Jobs

(Just Now) Reviews from Merrimack Pharmaceuticals employees about Merrimack Pharmaceuticals culture, salaries, benefits, work-life balance, management, job security, and more.

Url: Visit Now

Category:  Pharmaceutical Detail Drugs


MACK Merrimack Pharmaceuticals Inc. Stock Price & News - WSJ

(3 days ago) View the latest Merrimack Pharmaceuticals Inc. (MACK) stock price, news, historical charts, analyst ratings and financial information from WSJ.

Url: Visit Now

Category:  Pharmaceutical Detail Drugs


Merrimack Pharmaceuticals Tufts Student Services

(2 days ago) Merrimack Pharmaceuticals. Cambridge, Massachusetts. Integrated teams building integrated cancer regimens. At Merrimack, researchers, clinicians, professionals, and, yes, engineers work together in a multidisciplinary, team-based environment. All are committed to a single vision. Building cures for cancer.

Url: Visit Now

Category:  Pharmaceutical,  Cancer Detail Drugs


Working At Merrimack Pharmaceuticals: Employee Reviews and …

(2 days ago) The average employee at Merrimack Pharmaceuticals makes $91,037 per year. Pay at Merrimack Pharmaceuticals is significantly lower than some of its highest paying competitors, like Depomed, Gilead Sciences, and Forest Laboratories, which pay $110,188, $105,024, and $103,591, respectively. Based in Cambridge, MA, Merrimack

Url: Visit Now

Category:  Pharmaceutical Detail Drugs


Merrimack Pharmaceuticals, Inc. (MACK) Stock Forum

(6 days ago) Find the latest Merrimack Pharmaceuticals, Inc. (MACK) stock discussion in Yahoo Finance's forum. Share your opinion and gain insight from other stock traders and investors.

Url: Visit Now

Category:  Pharmaceutical Detail Drugs

Popular Searched

 › United healthcare nurse hotline number

 › Pharmacy student topic discussion ideas

 › Hershey medical center staff directory

 › United healthcare nurses hotline

 › Florida department of health contact number

 › Pay aarp united healthcare online

 › Tele behavioral health services

 › Silverscript formulary drug list 2022

 › Signs of drug abusers

 › Alliance ppo health insurance

Recently Searched

 › Types of gabapentin drugs

 › Iv pharmacy technician duties

 › American medical seminar cme

 › Pharmacy kroger marketplace harrison

 › Is health premium pre tax

 › Fort jackson refill pharmacy hours

 › Skin care manufacturing companies

 › Tricare prime remote vision coverage

 › Nursing standards of care examples

 › Medical office decoration ideas

FAQ about Merrimack Pharmaceuticals

What does Merrimack Pharmaceuticals do?

Something went wrong while loading Watchlist. Merrimack Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which engages in discovering, developing, and commercializing medicines consisting of novel therapeutics paired with diagnostics for the treatment of cancer. Its pipeline includes MM-131, MM-141, and MM-310.

How much money does Merrimack Pharmaceuticals make a year?

Merrimack Pharmaceuticals has a market capitalization of $50.51 million and generates $144.27 million in revenue each year. Merrimack Pharmaceuticals employs 27 workers across the globe.View Additional Information About Merrimack Pharmaceuticals.

Who buys Merrimack Pharmaceuticals (Mack) stock?

MACK stock was acquired by a variety of institutional investors in the last quarter, including Radnor Capital Management LLC. Company insiders that have bought Merrimack Pharmaceuticals stock in the last two years include Eric Andersen, Gary L Crocker, and Noah G Levy.

How many drugs does Merrimack have in clinical development?

Merrimack has four drugs in clinical development. ^ "Investors - Merrimack". ^ "Onivyde pegylated liposomal EPAR". European Medicines Agency (EMA). Retrieved 19 June 2020. ^ a b "Merrimack - Annual Report".